SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the completion of a major milestone in the commercialization of the world’s first handheld Integrated Optical Biosensor (IOBS) for the diagnosis of diseases and detection of viral and bacterial pathogens in humans and animals. The scientific team at Los Alamos National Laboratory (LANL) has recently completed development work on a new bench top of the IOBS system. Validation of the cholera assay begins while ongoing research continues to isolate specific tuberculosis biomarkers. Upon completion of this validation studies the system will be sent to Lathrop Engineering for miniaturizing into our hand held battery operating unit.
